In the 9 months since we launched Ratings, some folks have readily used them to score papers – we'd like them to be joined by more so that we can build a critical mass of opinion about the relative importance of papers, and allow ratings to highlight the ‘best’ papers. The opinion of one person, or two peer reviewers, or even a group of Board Members may not be as relevant as a group of interested and motivated readers and that's is what we are seeking to encourage with this post.
Archives for May 2008
Neuroscience is one of the biggest sections in PLoS ONE and of the 360+ neuroscience papers published since the journal's launch in December 2006, many fall within the fields of psychology and the evolution of the mind.
Two of the papers published in PLoS ONE this week generated some dinosaur-based headlines, although only one of the studies actually involved any dinosaurs, as anyone who has read the freely-available articles will know.
Since today (20 May) is the third annual international clinical trials day it seemed the perfect occasion to share some trials news with PLoS Medicine readers.
Many of you will know that new FDA legislation in the United States will require, from September 2008, public reporting of basic trial results within one year of study completion. Many organisations and institutions will now be thinking about how to comply with the new requirements. Some groups are coming together to discuss how to standardise and implement results disclosure — as they did for trial registration with the Ottawa Statements and the WHO International Standards of Trial Registration.
Over the past couple of weeks Josh Eveleth and I have answered journalists’ enquiries from many different pockets of the United States about the recently published paper by Majid Ezzati and colleagues. The research, which analyzes mortality data for every county in every US state over four decades, finds a steady increase in mortality inequality across counties between 1983 and 1999.
During the last week of April and the first week of May, PLoS ONE published over 100 papers, with another 57 following today. With such a great range of papers, covering topics from some very noisy bats and the eating habits of Paranthropus boisei, to endangered amphibians and substandard antimalarial drugs, it is perhaps unsurprising that PLoS ONE has recently been featured even more prominently in the news than usual.
Since we launched, the largest number of papers we have published in any discrete topic is Cell Signaling. We are excited that this community is responding to the PLoS ONE publishing model and we want to encourage more submissions! As part of this Call for Papers, we analyzed our Cell Signaling articles to see what is being published at PLoS ONE, and which papers are proving to be the most popular or the most interesting. These results can be read in this post.
Why Did the EPA Fire a Respected Toxicologist? A Longtime Defender of Scientific Integrity Speaks Out
Last week, the Chicago Tribune reported, the US Environmental Protection Agency forced the director of its Midwest Office to quit after she refused to let Dow Chemical off the hook for stalling on the cleanup of dioxin-contaminated soil stretching 50 miles from its Midland, Mich., plant. Regional Administrator Mary Gade had ordered Dow to dredge a number of dioxin hotspots over the past year and balked at the company’s attempts to negotiate a more comprehensive cleanup as stalling.
In a new PLoS Biology article, “The Challenge of Conserving Amphibian Megadiversity in Madagascar,” Franco Andreone et al. argue that governments and conservation organizations should invest in proactive efforts to protect amphibians in Madagascar, which harbors some of the richest groups of amphibian fauna in the world, before the populations go into decline. We asked Kevin Zippel, program director of the Amphibian Ark, created to keep “threatened amphibian species afloat” through captive management programs, to explain the value of the authors’ approach.